Double Point Ventures

Description

A venture capital fund investing in visionaries shaping the future of healthcare. With a proven track record of scaling category-defining companies, we’re partnering with the next generation of innovators, pushing the boundaries of science and bringing life-changing treatments from bench to bedside. Our investment focus encompasses therapeutics (small molecules, biologics, gene and cell therapies, precision medicine), diagnostics and devices (early-revenue and innovative platforms), and digital health and healthcare services (early revenue-stage cutting-edge models for improving care).

Double Point Ventures is a Boston-based early-stage venture capital firm investing in therapeutics (small molecules, biologics, gene/cell therapies), diagnostics and devices, and early-revenue digital health product companies — it backs product and drug innovation startups, not healthcare-services platform acquisitions.

Double Point Ventures is a pure biotech/life-sciences venture capital firm focused on therapeutics, diagnostics, and early-stage digital health product companies — not a buyer or platform acquirer of healthcare-services practices; its partners' backgrounds are in drug/biotech VC (Novartis Venture Fund, Agent Capital), not healthcare-services buyouts.

enriched 2026-05-05

Financials